Thursday October 9th Schedule SASAT 2008
Second International Summit on Generic Low Molecular Weight Heparins
Developmental, Regulatory and Clinical Issues
Objectives: To review the current recommendations from various professional organizations (IUA, I-CATH, NATF and SASAT) to approve generic antithrombotic drugs in particular generic low molecular weight heparins. In addition, we will also review the positions of US FDA, EMEA, USP, EP and other regulatory bodies on this matter.
Topics for Discussion:
This summit will also review the draft version of the white papers, which was developed during the 2007 international summit on generic antithrombotic drugs at New Delhi, India.
Chairs: Job Harenberg and Jawed Fareed
Cultural Program and Dinner
(*Note: Time allotted for each presentation is 20 minutes)